Cargando…
Lysine specific demethylase 1 is a molecular driver and therapeutic target in sarcoma
Sarcomas are a diverse group of tumors with numerous oncogenic drivers, and display varied clinical behaviors and prognoses. This complexity makes diagnosis and the development of new and effective treatments challenging. An incomplete understanding of both cell of origin and the biological drivers...
Autores principales: | Dreher, Rachel D., Theisen, Emily R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846348/ https://www.ncbi.nlm.nih.gov/pubmed/36686841 http://dx.doi.org/10.3389/fonc.2022.1076581 |
Ejemplares similares
-
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
por: Magliulo, Daniela, et al.
Publicado: (2018) -
Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein
por: Theisen, Emily R., et al.
Publicado: (2020) -
Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma
por: Theisen, Emily R, et al.
Publicado: (2014) -
Chemical Biology of Lysine Demethylases
por: Heightman, Tom D
Publicado: (2011) -
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
por: Kim, Dongha, et al.
Publicado: (2021)